View source for 5x8h


==Crystal structure of the ketone reductase ChKRED20 from the genome of Chryseobacterium sp. CA49==
<StructureSection load='5x8h' size='340' side='right'caption='[[5x8h]], [[Resolution|resolution]] 1.85&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[5x8h]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Chryseobacterium_sp._CA49 Chryseobacterium sp. CA49]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5X8H OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5X8H FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.85&#8491;</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5x8h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5x8h OCA], [https://pdbe.org/5x8h PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5x8h RCSB], [https://www.ebi.ac.uk/pdbsum/5x8h PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5x8h ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/X2D0L0_9FLAO X2D0L0_9FLAO] 
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
ChKRED20 is an efficient and robust anti-Prelog ketoreductase that can catalyze the reduction of ketones to chiral alcohols as pharmaceutical intermediates with great industrial potential. To overcome its limitation on the bioreduction of ortho-substituted acetophenone derivatives, the X-ray crystal structure of the apo-enzyme of ChKRED20 was determined at a resolution of 1.85 A and applied to the molecular modeling and reshaping of the catalytic cavity via three rounds of iterative saturation mutagenesis together with alanine scanning and recombination. The mutant Mut3B was achieved with expanded catalytic scope that covered all the nine substrates tested as compared with two substrates for the wild type. It exhibited 13-20-fold elevated k cat/K m values relative to the wild type or to the first gain-of-activity mutant, while retaining excellent stereoselectivity toward seven of the substrates (98-&gt; 99% ee). Another mutant 29G10 displayed complementary selectivity for eight of the ortho-substituted acetophenone derivatives, with six of them delivering excellent stereoselectivity (90-99% ee). Its k cat/K m value toward 1-(2-fluorophenyl)ethanone was 5.6-fold of the wild type. The application of Mut3B in elevated substrate concentrations of 50-100 g/l was demonstrated in 50-ml reactions, achieving 75-&gt; 99% conversion and &gt; 99% ee.

Crystal structure and iterative saturation mutagenesis of ChKRED20 for expanded catalytic scope.,Zhao FJ, Jin Y, Liu Z, Guo C, Li TB, Li ZY, Wang G, Wu ZL Appl Microbiol Biotechnol. 2017 Oct 24. doi: 10.1007/s00253-017-8556-2. PMID:29067484<ref>PMID:29067484</ref>

From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 5x8h" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Chryseobacterium sp. CA49]]
[[Category: Large Structures]]
[[Category: Jin Y]]
[[Category: Liu ZC]]
[[Category: Wang GG]]
[[Category: Wu ZL]]
[[Category: Zhao FJ]]